Mosa Moshabela

Matlagolo Mosa Moshabela is a South African medical doctor, academic, and researcher specializing in public health and primary health care. He is recognized for his contributions to health systems research, particularly in the areas of HIV/AIDS, tuberculosis and COVID-19. He has held key academic administrative roles and began his appointment as Vice-Chancellor of the University of Cape Town on 1 August 2024.^[2][3]

Mosa Moshabela was born and raised in South Africa. He pursued his medical degree at the University of KwaZulu-Natal, where he developed a strong interest in public health and primary care. Following his undergraduate studies, Moshabela completed a training in Family Medicine from MEDUNSA and subsequently earned a PhD in Public Health from the University of the Witwatersrand. He obtained a master's degree in Demography and Health from the London School of Hygiene and Tropical Medicine.^[4][5]

Moshabela has held various academic positions throughout his career. This includes being Dean^[6] of the School of Nursing and Public Health at the University of KwaZulu-Natal and subsequently Deputy Vice-Chancellor for research and Innovation. His academic work is characterized by a commitment to improving health care delivery and addressing the social determinants of health, particularly in sub-Saharan Africa.^[7]

Mosa Moshabela's research spans several critical areas in public health, including HIV/AIDS, tuberculosis, and health care delivery in resource-limited settings. He has led and participated in numerous research projects aimed at enhancing the understanding and management of these diseases. His work often involves interdisciplinary approaches, combining insights from medicine, public health, and social sciences.^[8]

Moshabela has published in peer-reviewed journals and has presented his research findings at various international conferences. His research has significantly influenced health policies and practices in South Africa and other parts of Africa.^[9]

In addition to his academic and research roles, Moshabela is actively involved in health advocacy. He works closely with various governmental and non-governmental organizations to improve health care access and quality. His leadership extends to several professional associations and health committees, where he contributes to shaping health policy and practice. He is the chair person of the National Research Foundation Board.^[10][11] He is a member of the Academy of Science of South Africa.^[12]

Moshabela has received numerous awards and honors in recognition of his contributions to public health and medical research. These accolades highlight his impact on improving health outcomes and his dedication to advancing health equity.^[13][14]

• Sandile Cele; Laurelle Jackson; David S Khoury; et al. (February 2022). "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization". Nature. 602 (7898): 654–656. Bibcode:2022Natur.602..654C. doi:10.1038/S41586-021-04387-1. ISSN 1476-4687. PMC 8866126. PMID 35016196. Wikidata Q112052343.
• Mosa Moshabela; Dominic Bukenya; Gabriel Darong; et al. (1 July 2017). "Traditional healers, faith healers and medical practitioners: the contribution of medical pluralism to bottlenecks along the cascade of care for HIV/AIDS in Eastern and Southern Africa". Sexually Transmitted Infections. 93 (Suppl 3). doi:10.1136/SEXTRANS-2016-052974. ISSN 1368-4973. PMC 5739844. PMID 28736393. Wikidata Q38557151.
• Jonathan E Golub; Paul Pronyk; Lerato Mohapi; et al. (1 March 2009). "Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort". AIDS. 23 (5): 631–636. doi:10.1097/QAD.0B013E328327964F. ISSN 0269-9370. PMC 3063949. PMID 19525621. Wikidata Q34717889.

• Mosa Moshabela publications indexed by Google Scholar
• Publications by Mosa Moshabela at ResearchGate

Scholia has an author profile for Mosa Moshabela.